JeNu Biosciences, founded in 2008, aims to revolutionize the beauty industry by leveraging innovative technology to deliver tangible results. The company's flagship product, the JeNu Ultrasonic Infuser, utilizes ultrasound technology to enhance the absorption of skincare products into the skin, resulting in a remarkable 6x increase in absorption and a 60% boost in consumer satisfaction. JeNu's approach fills a void in the market, as it focuses on integrating technology as a core solution for specific beauty challenges, rather than as an afterthought. In April 2014, the company secured a $1.15M Debt Financing investment to fuel its growth. Moving forward, JeNu plans to expand into various other beauty categories, offering tech-rooted products tailored to meet the demands of today's beauty consumer. With its unique positioning and promising solutions, JeNu Biosciences is poised to make a significant impact in the biotechnology and hardware industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $1.15M | - | 08 Apr 2014 | |
| Venture Round | $3.00M | 1 |
|
06 Jan 2012 |
| Series A | $500.00K | - | 01 Sep 2011 | |
| Seed Round | $250.00K | - | 13 Dec 2010 |
No recent news or press coverage available for JeNu Biosciences.
We care about your data, and we'd love to use cookies make your experience better.